- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
MRI, MRS scans reveal who will lose weight
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes.
MRI and MR spectroscopy can identify fat distribution within the body and thus determine who will benefit most from lifestyle changes. Study subjects whose health improved the most after lifestyle changes started out with lower baseline levels of abdominal and liver fat.
German researchers performed MRI and MR spectroscopy on 243 individuals prior to and nine months after a lifestyle intervention (weight loss of 5%, reduced fat intake, and moderate physical activity). Each of the participants was considered at risk of developing type 2 diabetes as a result of obesity.
After nine months, insulin sensitivity improved in 71% of the men and 58% of the women. Individuals with improved insulin sensitivity lost significant amounts of abdominal fat (19% for women and 20% for men) and liver fat (35% for women and 44% for men) (Radiol doi:10.1148/radiol.10092284).
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
